Correlation Between Sigilon Therapeutics and Zura Bio
Can any of the company-specific risk be diversified away by investing in both Sigilon Therapeutics and Zura Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sigilon Therapeutics and Zura Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sigilon Therapeutics and Zura Bio Limited, you can compare the effects of market volatilities on Sigilon Therapeutics and Zura Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sigilon Therapeutics with a short position of Zura Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sigilon Therapeutics and Zura Bio.
Diversification Opportunities for Sigilon Therapeutics and Zura Bio
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Sigilon and Zura is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sigilon Therapeutics and Zura Bio Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zura Bio Limited and Sigilon Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sigilon Therapeutics are associated (or correlated) with Zura Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zura Bio Limited has no effect on the direction of Sigilon Therapeutics i.e., Sigilon Therapeutics and Zura Bio go up and down completely randomly.
Pair Corralation between Sigilon Therapeutics and Zura Bio
If you would invest 2,111 in Sigilon Therapeutics on September 12, 2024 and sell it today you would earn a total of 0.00 from holding Sigilon Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 1.56% |
Values | Daily Returns |
Sigilon Therapeutics vs. Zura Bio Limited
Performance |
Timeline |
Sigilon Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Zura Bio Limited |
Sigilon Therapeutics and Zura Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sigilon Therapeutics and Zura Bio
The main advantage of trading using opposite Sigilon Therapeutics and Zura Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sigilon Therapeutics position performs unexpectedly, Zura Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zura Bio will offset losses from the drop in Zura Bio's long position.Sigilon Therapeutics vs. Reviva Pharmaceuticals Holdings | Sigilon Therapeutics vs. ZyVersa Therapeutics | Sigilon Therapeutics vs. Unicycive Therapeutics | Sigilon Therapeutics vs. Apollomics Class A |
Zura Bio vs. The Wendys Co | Zura Bio vs. CAVA Group, | Zura Bio vs. Dine Brands Global | Zura Bio vs. The Cheesecake Factory |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |